Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Pranlukast and mirabegron may work as new diabetes drugs.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Tazarotene gel may be more effective for acne than adapalene gel.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

The drug combination was safe and showed promise in treating advanced tumors.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.